Sua Luz F, Arias Daniela, Morales Eliana I, Bravo Juan C, Zúñiga-Restrepo Valeria, Fernández-Trujillo Liliana
Department of Pathology and Laboratory Medicine, Fundación Valle del Lili, Cali, Colombia.
Faculty of Health Sciences, Universidad Icesi, Cali, Colombia.
Respir Med Case Rep. 2020 Feb 22;29:101027. doi: 10.1016/j.rmcr.2020.101027. eCollection 2020.
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL) originated from mature post thymic T cells. They represent 1-3% of NHL. Different subtypes have been described: Anaplastic lymphoma kinase (ALK)-negative ALCL, ALK-positive ALCL and breast implant-associated ALCL. ALK-positive ALCL affects mainly the young and has better prognosis. We present a case report of an adult woman with AKL-positive ALCL, diagnosed by endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA). A 59-year-old women with no history of breast implants, was admitted for a four-month low back pain. Initially, the patient was treated for a spondyloarthropathy, but due to persistence of the symptoms, a lumbosacral MRI was performed, showing changes in morphology and signal intensity in the vertebral body of L3, along with edema and a paravertebral collection that affected the left psoas muscle, suggesting granulomatous spondylodiscitis. Chest CT-scan showed mild left pleural effusion, subcarinal and right hiliar adenomegalies. An EBUS-TBNA with ROSE (rapid on-site evaluation) was performed showing positive findings for malignancy, suggestive of hematolymphoid neoplasia. Pathology analysis showed an AKL-positive ALCL. Additionally, a biopsy of paravertebral tissue biopsy was obtained, which was consistent with the nodal sample. Chemotherapy was initiated with the CHOP protocol: cyclophosphamide, hydroxydaunorubicin, vincristine sulfate and prednisone. EBUS-TBNA is a minimally invasive and safe technique for obtaining mediastinal samples. Collaboration with a cytopathologist trained to perform ROSE improves the diagnostic performance.
间变性大细胞淋巴瘤(ALCL)是一种罕见的非霍奇金淋巴瘤(NHL),起源于成熟的胸腺后T细胞。它们占NHL的1%-3%。已经描述了不同的亚型:间变性淋巴瘤激酶(ALK)阴性ALCL、ALK阳性ALCL和乳房植入物相关ALCL。ALK阳性ALCL主要影响年轻人,预后较好。我们报告一例经支气管内超声引导下经支气管针吸活检(EBUS-TBNA)诊断为ALK阳性ALCL的成年女性病例。一名59岁无乳房植入史的女性因持续四个月的腰痛入院。最初,患者接受脊柱关节病治疗,但由于症状持续存在,进行了腰骶部MRI检查,显示L3椎体形态和信号强度改变,伴有水肿和影响左腰大肌的椎旁积液,提示肉芽肿性脊椎间盘炎。胸部CT扫描显示轻度左侧胸腔积液、隆突下和右肺门淋巴结肿大。进行了带有快速现场评估(ROSE)的EBUS-TBNA,结果显示恶性肿瘤阳性,提示血液淋巴系统肿瘤。病理分析显示为ALK阳性ALCL。此外,还获取了椎旁组织活检样本,与淋巴结样本一致。采用CHOP方案开始化疗:环磷酰胺、羟基柔红霉素、硫酸长春新碱和泼尼松。EBUS-TBNA是获取纵隔样本的一种微创且安全的技术。与经过培训能进行ROSE的细胞病理学家合作可提高诊断性能。